Post Guides FY27 Adjusted EBITDA to $1,450-$1,500M, Below FY26; Executive Chairman on Medical Leave
POST is trading near its 52-week low of $71.45 (11% above the low).
Summary
Post Holdings reported fiscal 2026 Adjusted EBITDA of $1,568.9 million but guided fiscal 2027 to $1,450-$1,500 million, a step down, while announcing the Executive Chairman's medical leave and two new board appointments.
Key Events · Earnings and Guidance · POST
-
FY27 Guidance Below FY26
Management expects fiscal 2027 Adjusted EBITDA of $1,450-$1,500 million versus $1,568.9 million in fiscal 2026, a decline of roughly 4% to 8% at the midpoint.
-
Q4 Sales and EBITDA Decline
Fourth-quarter net sales fell 13.0% to $1,954.5 million and Adjusted EBITDA fell 11.0% to $378.4 million, with Foodservice lapping prior-year avian influenza pricing.
-
Executive Chairman on Medical Leave
Robert V. Vitale began a medical leave effective November 18, 2026; director Jeff A. Zadoks is interim Chairman and CEO Nicolas Catoggio is sole principal executive officer.
-
Board Adds Two, One Retires
Christopher R. Growe and Nicholas P. Stiritz join the Board effective December 1, 2026; David P. Skarie retires effective January 15, 2027.
Analysis · POST · Manufacturing
Post closed fiscal 2026 with $1,568.9 million of Adjusted EBITDA but told investors to expect $1,450-$1,500 million in fiscal 2027 — a decline of roughly 4% to 8% at the midpoint, driven by lapping avian-influenza pricing in Foodservice and continued pet food and value cereal volume losses. The fourth quarter already showed the pressure: net sales fell 13.0% to $1,954.5 million and Adjusted EBITDA dropped 11.0% to $378.4 million. Layered on top is a leadership reshuffle — Executive Chairman Robert Vitale is on medical leave, director Jeff Zadoks steps in as interim Chairman, and CEO Nicolas Catoggio takes sole executive leadership — plus two new directors and the retirement of long-serving director David Skarie. The buyback remains active with $396.7 million left, but at 4.7x net leverage the company has limited room to offset the earnings step-down with repurchases.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, POST was trading at $79.59 on NYSE in the Manufacturing sector, with a market capitalization of approximately $3.5B. The 52-week trading range was $71.45 to $117.28. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.